152 related articles for article (PubMed ID: 2360820)
21. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
Schrinner E; Limbert M; Seeger K; Seibert G; Novick WJ
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):13S-20S. PubMed ID: 6086214
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of action of the new orally active cephalosporin FK027.
Shigi Y; Matsumoto Y; Kaizu M; Fujishita Y; Kojo H
J Antibiot (Tokyo); 1984 Jul; 37(7):790-6. PubMed ID: 6381449
[TBL] [Abstract][Full Text] [Related]
23. RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases.
Malouin F; Blais J; Chamberland S; Hoang M; Park C; Chan C; Mathias K; Hakem S; Dupree K; Liu E; Nguyen T; Dudley MN
Antimicrob Agents Chemother; 2003 Feb; 47(2):658-64. PubMed ID: 12543674
[TBL] [Abstract][Full Text] [Related]
24. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
Neu HC; Chin NX
Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
[TBL] [Abstract][Full Text] [Related]
25. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics.
Jones RN; Barry AL
Rev Infect Dis; 1983; 5 Suppl 1():S108-26. PubMed ID: 6221381
[TBL] [Abstract][Full Text] [Related]
26. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo activities of AM-112, a novel oxapenem.
Jamieson CE; Lambert PA; Simpson IN
Antimicrob Agents Chemother; 2003 May; 47(5):1652-7. PubMed ID: 12709336
[TBL] [Abstract][Full Text] [Related]
28. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Hikida M; Itahashi K; Igarashi A; Shiba T; Kitamura M
Antimicrob Agents Chemother; 1999 Aug; 43(8):2010-6. PubMed ID: 10428928
[TBL] [Abstract][Full Text] [Related]
29. Review of the in vitro spectrum of activity of imipenem.
Jones RN
Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
[TBL] [Abstract][Full Text] [Related]
30. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
Neu HC
Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of a catechol-substituted cephalosporin, GR69153.
Wise R; Andrews JM; Ashby JP; Thornber D
Antimicrob Agents Chemother; 1991 Feb; 35(2):329-34. PubMed ID: 2024966
[TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
Watanabe N; Katsu K; Moriyama M; Kitoh K
Antimicrob Agents Chemother; 1988 May; 32(5):693-701. PubMed ID: 3134847
[TBL] [Abstract][Full Text] [Related]
33. In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae.
Mendelman PM; Henritzy LL; Chaffin DO; Lent K; Smith AL; Stull TL; Wiley EA
Antimicrob Agents Chemother; 1989 Nov; 33(11):1878-82. PubMed ID: 2610499
[TBL] [Abstract][Full Text] [Related]
34. Pharmacology and toxicology of oral cephalosporins.
Gialdroni Grassi G
Antibiot Chemother (1971); 1995; 47():8-33. PubMed ID: 8554309
[No Abstract] [Full Text] [Related]
35. Affinities of cephalosporins for penicillin-binding proteins and their antibacterial activities in the presence of human serum albumin.
Fontana R; Ligozzi M; Cornaglia G
Clin Microbiol Infect; 2000; 6 Suppl 3():82-3. PubMed ID: 11449662
[No Abstract] [Full Text] [Related]
36. In vitro activity of BMY-28100, a new oral cephalosporin.
Eliopoulos GM; Reiszner E; Wennersten C; Moellering RC
Antimicrob Agents Chemother; 1987 Apr; 31(4):653-6. PubMed ID: 3496846
[TBL] [Abstract][Full Text] [Related]
37. Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
Piddock LJ; Traynor EA; Griggs DJ
Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):364-71. PubMed ID: 1396760
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.
Une T; Otani T; Sato M; Ikeuchi T; Osada Y; Ogawa H; Sato K; Mitsuhashi S
Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898
[TBL] [Abstract][Full Text] [Related]
39. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
Tsuchiya K; Kondo M; Kida M; Nakao M; Iwahi T; Nishi T; Noji Y; Takeuchi M; Nozaki Y
Antimicrob Agents Chemother; 1981 Jan; 19(1):56-65. PubMed ID: 6941742
[TBL] [Abstract][Full Text] [Related]
40. Penicillin-binding protein 5 as an inhibitory target of cefozopran in Enterococcus faecalis.
Tsuchimori N; Okonogi K
J Antimicrob Chemother; 1996 Mar; 37(3):605-9. PubMed ID: 9182117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
